OMAHA, Neb. and BELGRADE, Maine, Sept. 25, 2023 /PRNewswire/ -- Prostate cancer management reached a new pinnacle of precision with Bot Image's ProstatID using Bi-parametric MRI (bpMRI). The Nebrasksa ...
Certification opens the European market for the first FDA-cleared AI platform for prostate MRI interpretation. OMAHA, Neb., Oct. 27, 2025 /PRNewswire/ -- Bot Image, Inc., a leader in AI-powered ...
EDINBURGH, Scotland, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Blackford, the pioneering AI platform and solutions provider, and Bot Image today announced a commercial partnership to bring Bot Image’s ...
The U.S. FDA gave Bot Image Inc. a coveted threefer with 510(k) clearance for its Prostatid artificial intelligence (AI) software for detection, diagnosis and monitoring of prostate cancer using both ...
CEOCFO Interviews Bot Image, Inc. Founder/CEO Dr. Randall W. Jones, about their AI algorithm-based ProstatID™ for Prostate Cancer Detection Bot Image’s mission is to develop software tools using AI ...
"This CE certification represents a pivotal step in our mission to make early, accurate prostate cancer detection accessible to clinicians and patients worldwide," said Mike "Bing" Crosby, Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback